Skip to main content
Log in

7.3. Lower Within-Subject Variability in Mean Blood Glucose Concentration with Insulin Degludec vs. Insulin Glargine: A Meta-Analysis of Patients with T2D (914-P)

  • Congresverslag
  • Published:
Nederlands Tijdschrift voor Diabetologie Aims and scope

Samenvatting

Insulin degludec (IDeg) is a new ultra-long-acting basal insulin shown to have low day-to-day variability in a euglycemic clamp study. In this post-hoc meta-analysis of patients with T2D, we compared day-to-day variability in mean selfmeasured blood glucose (derived from 9-point profiles; 9P-SMPG) between IDeg and insulin glargine (IGlar).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Additional information

Miami, FL, London, ON, Canada, Cardiff, United Kingdom, Søborg, Denmark, Graz, Austria

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meneghini, L., Harris, S., Evans, M. et al. 7.3. Lower Within-Subject Variability in Mean Blood Glucose Concentration with Insulin Degludec vs. Insulin Glargine: A Meta-Analysis of Patients with T2D (914-P). NED. TIJDSCHR. DIABET. 11, 99–100 (2013). https://doi.org/10.1007/s12467-013-0054-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12467-013-0054-2

Navigation